2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association
Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and
kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic …
kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias
A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021 - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …
coverage in Japan in 1974, and its use rapidly became widespread thereafter …
[HTML][HTML] Efficacy and safety of an extravascular implantable cardioverter–defibrillator
P Friedman, F Murgatroyd, LVA Boersma… - … England Journal of …, 2022 - Mass Medical Soc
Background The extravascular implantable cardioverter–defibrillator (ICD) has a single lead
implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and …
implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and …
European Heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections …
C Blomström-Lundqvist, V Traykov… - European Journal of …, 2020 - academic.oup.com
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …
Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial
MR Gold, PD Lambiase, MF El-Chami, RE Knops… - Circulation, 2021 - Am Heart Assoc
Background: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and
effective for sudden cardiac death prevention. However, patients in previous S-ICD studies …
effective for sudden cardiac death prevention. However, patients in previous S-ICD studies …
Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
PD Lambiase, DA Theuns, F Murgatroyd… - European Heart …, 2022 - academic.oup.com
Aims To report 5-year outcomes of EFFORTLESS registry patients with early generation
subcutaneous implantable cardioverter-defibrillator (S-ICD) devices. Methods and results …
subcutaneous implantable cardioverter-defibrillator (S-ICD) devices. Methods and results …
[HTML][HTML] Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter …
DAMJ Theuns, TF Brouwer, PW Jones, V Allavatam… - Heart Rhythm, 2018 - Elsevier
Background Most inappropriate shocks from the subcutaneous implantable cardioverter-
defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology …
defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology …
The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause–aims, function and structure: Position paper of the Association for …
C Sinning, I Ahrens, A Cariou, F Beygui… - … Heart Journal: Acute …, 2020 - academic.oup.com
Approximately 10% of patients resuscitated from out-of-hospital cardiac arrest survive to
hospital discharge. Improved management to improve outcomes is required, and it is …
hospital discharge. Improved management to improve outcomes is required, and it is …